Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia
Crossref DOI link: https://doi.org/10.1186/s12894-017-0275-6
Published Online: 2017-09-12
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sicras-Mainar, Antoni
Navarro-Artieda, Ruth
Mora, Ana Mª.
Hernández, Marta